Global Compounding Pharmacies Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2023 to 2030

Description

List of Tables

The global demand for Compounding Pharmacies Market is presumed to reach the market size of nearly USD 28.23 BN by 2030 from USD 14.44 BN in 2022 with a CAGR of 8.74% under the study period 2023 - 2030.

Compounding pharmacies are a safe and reliable way to receive customized medications. Compounding pharmacies are specific types of pharmacies. Compounding pharmacies are to make drugs prescribed by doctors for specific patients with needs that commercially available drugs cannot meet. Compounding pharmacies can create customized dosage forms based on patient preferences and restrictions. Compounding pharmacies will only issue those medications obtained via a doctor's prescription. Compounding pharmacies undergo an extra quality assessment to assure consumers that the product has been compounded to compounding standards.

MARKET DYNAMICS

The chronic diseases such as cancer are becoming more common along with increasing funding for compounding pharmacies will boost the market over the forecast period. Also, the shortage of drugs is a strong reason for the growth of compounding pharmacies across the region. Moreover, the growing awareness about the benefits of compounded medications will lead to higher use of such personalized medications and result in market growth. The surging investments by the key market players in research and development to innovate and customize the formulations to effectively treat various diseases are expected to boost the growth of the compounding pharmacies market. However, increased restrictions on manufacturing complex formulations may hinder the market growth.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of compounding pharmacies. The growth and trends of compounding pharmacies industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the compounding pharmacies market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Therapeutic Area

Dermatology
Pain Management
Specialty Drugs
Nutritional Supplements
Hormone Replacement
Others

By Product

Oral (Solid Preparations, Liquid Preparations)
Topical (Creams, Gels, Ointments, Pastes, Others
Rectal (Enema, Suppositories, Others)
Parenteral (LVP, SVP)
Ophthalmic
Nasal
Otic

By Application

Pediatric
Geriatric
Adult
Veterinary

By Compounding Type

Pharmaceutical Dosage Alteration (PDA)
Pharmaceutical Ingredient Alteration (PIA)
Currently Unavailable Pharmaceutical Manufacturing (CUPM)
Others

By Sterility

Non-Sterile
Sterile

By Distribution Channel

Compounding Pharmacy
Hospital Pharmacy
Others

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Compounding Pharmacies market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the compounding pharmacies market include Fagron, B. Braun, Nephron Pharmaceuticals Corporation, Fresenius Kabi, Athenex Pharma Solutions (Athenex Inc.), Dougherty's Pharmacy, Inc., Clinigen Group PLC, Pencol Compounding Pharmacy, Lorraine's Pharmacy, McGuff Company Inc. (McGuff Compounding Pharmacy Services), Institutional Pharmacy Solutions, Rx3 Compounding Pharmacy, Wedgewood Village Pharmacy, Inc. and Triangle Compounding Pharmacies. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

Product Code: VMR11219448

1 . PREFACE

1.1. Report Description
- 1.1.1. Objective
- 1.1.2. Target Audience
- 1.1.3. Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1. Market Research Process
- 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3 . COMPOUNDING PHARMACIES - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Therapeutic Area
- 3.7.2 Market Attractiveness Analysis By Product
- 3.7.3 Market Attractiveness Analysis By Application
- 3.7.4 Market Attractiveness Analysis By Compounding Type
- 3.7.5 Market Attractiveness Analysis By Sterility
- 3.7.6 Market Attractiveness Analysis By Distribution Channel
- 3.7.7 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1. List of Raw Materials
- 4.2.2. Raw Material Manufactures List
- 4.2.3. Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1. Direct Marketing
- 4.4.2. Indirect Marketing
- 4.4.3. Marketing Channel Development Trend

5 . IMPACT ANALYSIS OF COVID-19 OUTBREAK

6 . GLOBAL COMPOUNDING PHARMACIES MARKET ANALYSIS BY THERAPEUTIC AREA

6.1 Overview by Therapeutic Area
6.2 Historical and Forecast Data
6.3 Analysis by Therapeutic Area
6.4 Dermatology Historic and Forecast Sales by Regions
6.5 Pain Management Historic and Forecast Sales by Regions
6.6 Specialty Drugs Historic and Forecast Sales by Regions
6.7 Nutritional Supplements Historic and Forecast Sales by Regions
6.8 Hormone Replacement Historic and Forecast Sales by Regions
6.9 Others Historic and Forecast Sales by Regions

7 . GLOBAL COMPOUNDING PHARMACIES MARKET ANALYSIS BY PRODUCT

7.1 Overview by Product
7.2 Historical and Forecast Data
7.3 Analysis by Product
7.4 Oral (Solid Preparations, Liquid Preparations) Historic and Forecast Sales by Regions
7.5 Topical (Creams, Gels, Ointments, Pastes, Others Historic and Forecast Sales by Regions
7.6 Rectal (Enema, Suppositories, Others) Historic and Forecast Sales by Regions
7.7 Parenteral (LVP, SVP) Historic and Forecast Sales by Regions
7.8 Ophthalmic Historic and Forecast Sales by Regions
7.9 Nasal Historic and Forecast Sales by Regions
7.10. Otic Historic and Forecast Sales by Regions

8 . GLOBAL COMPOUNDING PHARMACIES MARKET ANALYSIS BY APPLICATION

8.1 Overview by Application
8.2 Historical and Forecast Data
8.3 Analysis by Application
8.4 Pediatric Historic and Forecast Sales by Regions
8.5 Geriatric Historic and Forecast Sales by Regions
8.6 Adult Historic and Forecast Sales by Regions
8.7 Veterinary Historic and Forecast Sales by Regions

9 . GLOBAL COMPOUNDING PHARMACIES MARKET ANALYSIS BY COMPOUNDING TYPE

9.1 Overview by Compounding Type
9.2 Historical and Forecast Data
9.3 Analysis by Compounding Type
9.4 Pharmaceutical Dosage Alteration (PDA) Historic and Forecast Sales by Regions
9.5 Pharmaceutical Ingredient Alteration (PIA) Historic and Forecast Sales by Regions
9.6 Currently Unavailable Pharmaceutical Manufacturing (CUPM) Historic and Forecast Sales by Regions
9.7 Others Historic and Forecast Sales by Regions

10 . GLOBAL COMPOUNDING PHARMACIES MARKET ANALYSIS BY STERILITY

10.1 Overview by Sterility
10.2 Historical and Forecast Data
10.3 Analysis by Sterility
10.4 Non-sterile Historic and Forecast Sales by Regions
10.5 Sterile Historic and Forecast Sales by Regions

11 . GLOBAL COMPOUNDING PHARMACIES MARKET ANALYSIS BY DISTRIBUTION CHANNEL

11.1 Overview by Distribution Channel
11.2 Historical and Forecast Data
11.3 Analysis by Distribution Channel
11.4 Compounding Pharmacy Historic and Forecast Sales by Regions
11.5 Hospital Pharmacy Historic and Forecast Sales by Regions
11.6 Others Historic and Forecast Sales by Regions

12 . GLOBAL COMPOUNDING PHARMACIES MARKET SALES ANALYSIS BY GEOGRAPHY

12.1. Regional Outlook
12.2. Introduction
12.3. North America Sales Analysis
- 12.3.1. Overview, Historic and Forecast Sales Analysis
- 12.3.2. North America By Segment Sales Analysis
- 12.3.3. North America By Country Sales Analysis
- 12.3.4. United State Sales Analysis
- 12.3.5. Canada Sales Analysis
- 12.3.6. Mexico Sales Analysis
12.4. Europe Sales Analysis
- 12.4.1. Overview, Historic and Forecast Sales Analysis
- 12.4.2. Europe by Segment Sales Analysis
- 12.4.3. Europe by Country Sales Analysis
- 12.4.4. United Kingdom Sales Analysis
- 12.4.5. France Sales Analysis
- 12.4.6. Germany Sales Analysis
- 12.4.7. Italy Sales Analysis
- 12.4.8. Russia Sales Analysis
- 12.4.9. Rest Of Europe Sales Analysis
12.5. Asia Pacific Sales Analysis
- 12.5.1. Overview, Historic and Forecast Sales Analysis
- 12.5.2. Asia Pacific by Segment Sales Analysis
- 12.5.3. Asia Pacific by Country Sales Analysis
- 12.5.4. China Sales Analysis
- 12.5.5. India Sales Analysis
- 12.5.6. Japan Sales Analysis
- 12.5.7. South Korea Sales Analysis
- 12.5.8. Australia Sales Analysis
- 12.5.9. Rest Of Asia Pacific Sales Analysis
12.6. Latin America Sales Analysis
- 12.6.1. Overview, Historic and Forecast Sales Analysis
- 12.6.2. Latin America by Segment Sales Analysis
- 12.6.3. Latin America by Country Sales Analysis
- 12.6.4. Brazil Sales Analysis
- 12.6.5. Argentina Sales Analysis
- 12.6.6. Peru Sales Analysis
- 12.6.7. Chile Sales Analysis
- 12.6.8. Rest of Latin America Sales Analysis
12.7. Middle East & Africa Sales Analysis
- 12.7.1. Overview, Historic and Forecast Sales Analysis
- 12.7.2. Middle East & Africa by Segment Sales Analysis
- 12.7.3. Middle East & Africa by Country Sales Analysis
- 12.7.4. Saudi Arabia Sales Analysis
- 12.7.5. UAE Sales Analysis
- 12.7.6. Israel Sales Analysis
- 12.7.7. South Africa Sales Analysis
- 12.7.8. Rest Of Middle East And Africa Sales Analysis

13 . COMPETITIVE LANDSCAPE OF THE COMPOUNDING PHARMACIES COMPANIES

13.1. Compounding Pharmacies Market Competition
13.2. Partnership/Collaboration/Agreement
13.3. Merger And Acquisitions
13.4. New Product Launch
13.5. Other Developments

14 . COMPANY PROFILES OF COMPOUNDING PHARMACIES INDUSTRY

14.1. Top Company Share Analysis
14.2. Market Concentration Rate
14.3. Fagron
- 14.3.1. Company Overview
- 14.3.2. Company Revenue
- 14.3.3. Products
- 14.3.4. Recent Developments
14.4. B. Braun
- 14.4.1. Company Overview
- 14.4.2. Company Revenue
- 14.4.3. Products
- 14.4.4. Recent Developments
14.5. Nephron Pharmaceuticals Corporation
- 14.5.1. Company Overview
- 14.5.2. Company Revenue
- 14.5.3. Products
- 14.5.4. Recent Developments
14.6. Fresenius Kabi
- 14.6.1. Company Overview
- 14.6.2. Company Revenue
- 14.6.3. Products
- 14.6.4. Recent Developments
14.7. Athenex Pharma Solutions (Athenex Inc.)
- 14.7.1. Company Overview
- 14.7.2. Company Revenue
- 14.7.3. Products
- 14.7.4. Recent Developments
14.8. Dougherty's Pharmacy Inc.
- 14.8.1. Company Overview
- 14.8.2. Company Revenue
- 14.8.3. Products
- 14.8.4. Recent Developments
14.9. Clinigen Group PLC
- 14.9.1. Company Overview
- 14.9.2. Company Revenue
- 14.9.3. Products
- 14.9.4. Recent Developments
14.10. Pencol Compounding Pharmacy
- 14.10.1. Company Overview
- 14.10.2. Company Revenue
- 14.10.3. Products
- 14.10.4. Recent Developments
14.11. Lorraine's Pharmacy
- 14.11.1. Company Overview
- 14.11.2. Company Revenue
- 14.11.3. Products
- 14.11.4. Recent Developments
14.12. McGuff Company Inc. (McGuff Compounding Pharmacy Services)
- 14.12.1. Company Overview
- 14.12.2. Company Revenue
- 14.12.3. Products
- 14.12.4. Recent Developments
14.13. Institutional Pharmacy Solutions
- 14.13.1. Company Overview
- 14.13.2. Company Revenue
- 14.13.3. Products
- 14.13.4. Recent Developments
14.14. Rx3 Compounding Pharmacy
- 14.14.1. Company Overview
- 14.14.2. Company Revenue
- 14.14.3. Products
- 14.14.4. Recent Developments
14.15. Wedgewood Village Pharmacy Inc.
- 14.15.1. Company Overview
- 14.15.2. Company Revenue
- 14.15.3. Products
- 14.15.4. Recent Developments
14.16. Triangle Compounding Pharmacies
- 14.16.1. Company Overview
- 14.16.2. Company Revenue
- 14.16.3. Products
- 14.16.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies